These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2261014)

  • 61. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 62. Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.
    Kimball SD; Floyd DM; Das J; Hunt JT; Krapcho J; Rovnyak G; Duff KJ; Lee VG; Moquin RV; Turk CF
    J Med Chem; 1992 Feb; 35(4):780-93. PubMed ID: 1311765
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.
    Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Dec; 3(4):337-41. PubMed ID: 3255335
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aminoalkynyldithianes. A new class of calcium channel blockers.
    Adams TC; Dupont AC; Carter JP; Kachur JF; Guzewska ME; Rzeszotarski WJ; Farmer SG; Noronha-Blob L; Kaiser C
    J Med Chem; 1991 May; 34(5):1585-93. PubMed ID: 2033584
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Selective and specific reduction in the heart rate: a promising direction in the creation of new cardiovascular drugs].
    Chichkanov GG; Tsorin IB
    Eksp Klin Farmakol; 2007; 70(4):66-71. PubMed ID: 18078045
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.
    Campiani G; Garofalo A; Fiorini I; Botta M; Nacci V; Tafi A; Chiarini A; Budriesi R; Bruni G; Romeo MR
    J Med Chem; 1995 Oct; 38(22):4393-410. PubMed ID: 7473567
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cardiomyocyte culture as a highly sensitive system for testing pharmacological activity of specific bradycardic agents].
    Neverova ME; Mkrtumova NA; Fidelina OV; Adamskaia EI; Tsorin IB; Chichkanov GG; Chudakov LI
    Eksp Klin Farmakol; 2006; 69(5):24-6. PubMed ID: 17153961
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M; Shimotori M; Ogiwara Y; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):72-82. PubMed ID: 3485962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
    Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
    Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Search for new Ca++ antagonists. Lipophilic oximes and phosphonates.
    Bellucci C; Teodori E; Gualtieri F; Piacenza G
    Farmaco Sci; 1985 Oct; 40(10):730-44. PubMed ID: 3002848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis, pharmacological characterization, and quantitative structure-activity relationship analyses of 3,7,9,9-tetraalkylbispidines: derivatives with specific bradycardic activity.
    Schön U; Antel J; Brückner R; Messinger J; Franke R; Gruska A
    J Med Chem; 1998 Jan; 41(3):318-31. PubMed ID: 9464363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs.
    Riley DC; Gross GJ; Kampine JP; Warltier DC
    Anesthesiology; 1987 Nov; 67(5):707-16. PubMed ID: 3674471
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
    Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
    J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
    Gubin J; de Vogelaer H; Inion H; Houben C; Lucchetti J; Mahaux J; Rosseels G; Peiren M; Clinet M; Polster P
    J Med Chem; 1993 May; 36(10):1425-33. PubMed ID: 8496910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New benzoxazine and benzothiazine derivatives--structure-activity relations in guinea-pig heart and smooth muscle preparations.
    Studenik C; Lemmens-Gruber R; Heistracher P
    Pharmazie; 1999 May; 54(5):330-4. PubMed ID: 10368825
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of a new bradycardic substance on the isolated rabbit heart].
    Granetzny A; Schwanke U; Schmitz C; Schmitz-Spanke S; Arnold G; Schulte HD; Schipke JD
    Z Kardiol; 1996 Dec; 85(12):953-60. PubMed ID: 9082674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.